研究单位：[1]Beijing Hospital[2]The First Affiliated Hospital of China University of Science and Technology (Anhui Provincial)[3]Peking University People's Hospital[4]Peking University Third Hospital[5]First Affiliated Hospital, Sun Yat-Sen University[6]Guangdong Provincial People's Hospital[7]The First Affiliated Hospital of Zhengzhou University[8]Wuhan Union Hospital, China[9]Second Xiangya Hospital of Central South University[10]Xiangya Hospital of Central South University[11]The Affiliated Hospital of Inner Mongolia Medical University[12]First Hospital of China Medical University[13]Shandong Provincial Hospital[14]Changhai Hospital[15]RenJi Hospital[16]Shanxi Bethune Hospital[17]West China Hospital[18]Institute of Hematology & Blood Diseases Hospital, China[19]Tianjin First Central Hospital[20]Tianjin Medical University General Hospital[21]People's Hospital of Xinjiang Uygur Autonomous Region[22]The First People's Hospital of Yunnan
The goal of this clinical trial is to evaluate the efficacy and safety of Telitacicept for the treatment of connective tissue disease-associated thrombocytopenia.
